Independent research tool — not a government agency. Official notices govern.Refreshed
ForecastedResearch announcementOpportunity RFA-DK-28-112

NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)

National Institutes of Health · Department of Health and Human Services

At a glance

NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional) is a forecasted federal grant opportunity from the National Institutes of Health (Department of Health and Human Services). The agency's forecast estimates an application due date of June 1, 2027; forecast dates can change. Total estimated funding is $28M across about 30 awards. Applicant types listed as eligible include state governments, county governments, city or township governments, special district governments, independent school districts and 10 more. Cost sharing is not required. It is funded under Assistance Listing 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

  1. Jul 2, 2026Forecast posted
  2. Apr 30, 2027 (est.)Full notice expectednext date
  3. Jun 1, 2027 (est.)Application deadline
  4. Mar 31, 2028 (est.)Est. award date
Posted
Jul 2, 2026
Est. close date
Jun 1, 2027
Est. award date
Mar 31, 2028
Award floor
Not specified
Award ceiling
Not specified
Est. total funding
$28,000,000
Implied average award
$933,333 calculated
Expected awards
30
Cost sharing
Not required
Funding instrument
Grant
Opportunity category
Discretionary
Fiscal year
FY2028

Typical awards for this program (SAM.gov listing for ALN 93.847, not this notice): Project Grants: Range of $1,300 to $10,834,000; $418,000 average NRSAs: Range of $2,500 to $869,000; $116,000 average SBIR: Range of $6,500 to $2,074,000; $585,000 average

Implied average = estimated total funding ÷ expected number of awards, calculated by GrantsJunction. Actual awards vary.

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public colleges & universities
  • Federally recognized tribal governments
  • Public & Indian housing authorities
  • Native American tribal organizations
  • 501(c)(3) nonprofits
  • Nonprofits without 501(c)(3) status
  • Private colleges & universities
  • For-profit organizations (not small businesses)
  • Small businesses
  • Others (see notice)

Additional information on eligibility (from the notice)

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;

A quick check against the listed applicant types — other requirements in the notice still apply.

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

This Notice of Funding Opportunity (NOFO) invites applications for NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional). These Core Centers are part of an integrated program of biomedical and translational research supporting our cystic fibrosis, diabetes, nutrition, obesity, liver and digestive diseases research. They enhance multidisciplinary collaboration, rigor, reproducibility, replication and research cost efficiencies at institutions that already have a large established research base in one of the above focused areas within NIDDK’s mission. They should also provide a rich mentoring environment for trainees and early-stage investigators. The P30 Centers accomplish their purpose by providing a Pilot and Feasibility Grant Program, a Scientific Catalyst Program, and importantly shared access to the services of Cores. Within a given P30 Center, the Scientific Catalyst Program, which works within the Administrative Core, supports activities that strengthen the Center’s scientific community and advance its research mission. Activities may include research team building, investigator mentoring, seminars, workshops, visiting scientists, and scientific research series. The program is intended to foster multidisciplinary collaboration, attract new investigators, and engage investigators with expertise relevant to the Center’s chronic disease research focus. The Core Services reflect the research needs of the Center and may include research consultation along with services involving cell or other models, planning, analysis, hands-on services, access to expensive specialized equipment, other technical resources or training shared by the Center members and operated or overseen by recognized experts.

How to apply

0 of 8 done · progress saved in this browser

Assistance Listing

What is an ALN?

Reported obligations under ALN 93.847

Historical data · not a prediction
FY24$1.97B
FY25$2.04B
FY26$111M est.
Source: SAM.gov Assistance Listing 93.847. Program-wide totals, not awards from this specific opportunity.

Agency contact (as published)

NIDDKP30s@NIH.gov
NIDDKP30s@NIH.gov
NIDDKP30s@NIH.gov

Quick answers

Is “NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)” open for applications yet?

Not yet. It is a forecast — an agency's advance notice of an expected opportunity. The agency estimates posting the full notice around April 30, 2027. Forecast details and dates can change.

Who is eligible to apply for “NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)”?

The official notice lists these applicant types as eligible: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Public & Indian housing authorities, Native American tribal organizations, 501(c)(3) nonprofits, Nonprofits without 501(c)(3) status, Private colleges & universities and 3 more. Additional restrictions may apply; review the full notice.

How much funding is available through “NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)”?

Per the notice, total estimated program funding is $28,000,000 and the agency expects to make about 30 awards.

How do I apply for “NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)”?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity RFA-DK-28-112), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.